Fig. 2: Event-free survival of TdT-negative and TdT-positive B-ALL.
From: Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia
Event-free survival (EFS) of TdT-positive and TdT-negative B-ALL patients from Total XV and XVI clinical trials was estimated using the Kaplan-Meier method and compared with the log-rank test. Tick marks indicate data censored at the time of last follow-up.
